🌏 Asia
13h ago
Sun Pharma shares down 4 per cent on reports of overtures for US-based Organon
Source ↗
👁 0
💬 0
On reports of making a bid for Organon, Sun Pharma told BSE: “the information set out in the article is speculative in nature and there is no material event/information that requires disclosure under Regulation 30 of the Listing Regulations.”
Comments (0)